awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33322921-218CBA6F-970B-475D-9C25-03C3F6B146CD
Q33322921-218CBA6F-970B-475D-9C25-03C3F6B146CD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33322921-218CBA6F-970B-475D-9C25-03C3F6B146CD
Alternate day pomalidomide retains anti-myeloma effect with reduced adverse events and evidence of in vivo immunomodulation.
P2860
Q33322921-218CBA6F-970B-475D-9C25-03C3F6B146CD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33322921-218CBA6F-970B-475D-9C25-03C3F6B146CD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
527ca819c100cc85895ffa17064fa26d5320c8db
P2860
A systematic review of phase-II trials of thalidomide monotherapy in patients with relapsed or refractory multiple myeloma.